학술논문

PIVAS药师参与静脉用药不良反应主动监测工作模式初探 / Preliminary study of PIVAS pharmacists involved in the active monitoring of intravenous adverse drug reactions
Document Type
Academic Journal
Source
中国处方药 / Journal Of China Prescription Drug. 22(1):91-94
Subject
PIVAS药师
血必净注射液
ADR主动监测
工作模式
PIVAS pharmacist
Xuebijing Injection
ADR active monitoring
Working mode
Language
Chinese
ISSN
1671-945X
Abstract
目的 探讨静脉药物配置中心(PIVAS)药师参与静脉用药不良反应(ADR)主动监测的工作模式.方法 收集 2021 年所有使用血必净注射液(规格 10 ml,天津红日药业股份有限公司)住院患者的用药数据,PIVAS药师参与临床ADR主动监测,建立PIVAS药师参与临床ADR主动监测工作模式.结果 收集到 2021 年使用血必净注射液所有住院患者共计 1 468 例,PIVAS药师参与 3 例血必净注射液ADR主动监测,PIVAS药师参与临床ADR监测后明显地发现了许多隐藏的和因不合理给药引起的ADR.结论 以血必净注射液为例,PIVAS药师在审核静脉用药医嘱基础上参与ADR主动监测,建立PIVAS药师参与静脉用药ADR主动监测工作模式,改变以往被动监测模式使其变为主动监测模式,提高了ADR上报率,降低了医师漏报率,也提高了ADR上报质量,可促进医院ADR监测工作的高效开展.
Objective Explore the working mode of pharmacists in PIVAS to participate in the active monitoring of intravenous ADR.Methods Data on the use of Xuebijing Injection(10 ml,Tianjin Hongri Pharmaceutical Co.,Ltd.)were collected from all in-patients in the 2021.PIVAS pharmacists participated in the active ADR monitoring,to establish the active monitoring model of PIVAS pharmacists participating in clinical ADR.Results A total of 1 468 in-patients using Xuebijing Injection were collected in 2021.PIVAS pharmacists participated in the active monitoring of 3 cases of Xuebijing Injection ADR,PIVAS pharmacists who participated in the clinical ADR monitoring clearly found many hidden and caused by the irrational administration of ADR.Conclusion Taking Xuebijing Injection as an example,PIVAS pharmacists participate in ADR active monitoring based on the examination of intravenous medication orders,and establish the active monitoring mode of PIVAS pharmacists participating in intravenous medication ADR,the change from passive monitoring to active monitoring can improve the reporting rate of ADR,reduce the rate of doctors missing reporting,and improve the quality of ADR reporting,which can promote the efficient development of hospital ADR monitoring.